Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer | 94 |
Total Visits per Month
| November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|
| A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer | 15 | 8 | 5 | 3 | 8 | 16 | 8 |
File Downloads
| Views | |
|---|---|
| hdl_139466.pdf | 32 |
| hdl_139466.pdf | 1 |
Top Country Views
| Views | |
|---|---|
| United States | 39 |
| Singapore | 8 |
| Ireland | 6 |
| Belgium | 5 |
| China | 5 |
| Argentina | 3 |
| Hong Kong SAR China | 2 |
| Sweden | 2 |
| Australia | 1 |
| Nigeria | 1 |
Top City Views
| Views | |
|---|---|
| Ashburn | 8 |
| New York | 6 |
| Brussels | 5 |
| Clonee | 5 |
| Singapore | 5 |
| Boardman | 2 |
| Central | 2 |
| Hanover | 2 |
| Dublin | 1 |
| Lagos | 1 |